Vault-13

Nan Fung Group Holdings Ltd

KAI TAK, K3 · CIK 1782539 · 13F filing filed 2026-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$131.5m reported value +8.4% vs Q1 2026
25positions
82.4%in top 10
2 new 1 added 2 reduced 1 sold out vs Q1 2026

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MAPLIGHT THERAPEUTICS INC COM MPLT MPLT 971,253 $34.8m26.47% 26.47% UnchangedShares held: Q3 2025 0, Q4 2025 971.3k, Q1 2026 971.3k, Q2 2026 971.3k
2 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 630,657 $20.5m15.57% 15.57% UnchangedShares held: Q3 2025 300.0k, Q4 2025 300.0k, Q1 2026 630.7k, Q2 2026 630.7k
3 EVOMMUNE INC COM SHS EVMN EVMN 1,441,032 $19.2m14.56% 14.56% UnchangedShares held: Q3 2025 0, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
4 CYBIN INC COM NEW COM NEW 987,222 $6.5m4.96% 4.96% AddedShares held: Q3 2025 0, Q4 2025 460.0k, Q1 2026 460.0k, Q2 2026 987.2k +527.2k +527,222 114.6%
5 INCYTE CORP COM INCY INCY 53,742 $6.1m4.63% 4.63% UnchangedShares held: Q3 2025 59.0k, Q4 2025 59.0k, Q1 2026 53.7k, Q2 2026 53.7k
6 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 49,120 $5.5m4.15% 4.15% UnchangedShares held: Q3 2025 49.1k, Q4 2025 49.1k, Q1 2026 49.1k, Q2 2026 49.1k
7 BEIGENE LTD SPONSORED ADR ONC ONC 15,722 $4.5m3.41% 3.41% UnchangedShares held: Q3 2025 15.7k, Q4 2025 15.7k, Q1 2026 15.7k, Q2 2026 15.7k
8 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 300,565 $4.2m3.17% 3.17% ReducedShares held: Q3 2025 514.7k, Q4 2025 514.7k, Q1 2026 350.7k, Q2 2026 300.6k -50.2k -50,180 -14.3%
9 ASCENDIS PHARMA A/S ORD SHS ASND ASND 13,600 $3.6m2.76% 2.76% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.6k
10 REVOLUTION MEDICINES INC COM RVMD RVMD 19,253 $3.6m2.74% 2.74% UnchangedShares held: Q3 2025 19.3k, Q4 2025 19.3k, Q1 2026 19.3k, Q2 2026 19.3k
11 KYMERA THERAPEUTICS INC COM KYMR KYMR 30,875 $3.5m2.69% 2.69% UnchangedShares held: Q3 2025 30.9k, Q4 2025 30.9k, Q1 2026 30.9k, Q2 2026 30.9k
12 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 5,672 $3.0m2.32% 2.32% UnchangedShares held: Q3 2025 11.9k, Q4 2025 11.9k, Q1 2026 5.7k, Q2 2026 5.7k
13 CELCUITY INC COM CELC CELC 28,300 $3.0m2.25% 2.25% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.3k, Q2 2026 28.3k
14 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 102,984 $2.6m1.98% 1.98% UnchangedShares held: Q3 2025 103.0k, Q4 2025 103.0k, Q1 2026 103.0k, Q2 2026 103.0k
15 ARGENX SE SPONSORED ADR ARGX ARGX 2,800 $2.6m1.98% 1.98% UnchangedShares held: Q3 2025 2.8k, Q4 2025 2.8k, Q1 2026 2.8k, Q2 2026 2.8k
16 RECURSION PHARMACEUTICALS IN CL A RXRX RXRX 595,287 $2.2m1.66% 1.66% UnchangedShares held: Q3 2025 595.3k, Q4 2025 595.3k, Q1 2026 595.3k, Q2 2026 595.3k
17 PROCORE TECHNOLOGIES INC COM PCOR PCOR 53,299 $2.2m1.65% 1.65% UnchangedShares held: Q3 2025 0, Q4 2025 53.3k, Q1 2026 53.3k, Q2 2026 53.3k
18 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 27,049 $984.9k0.75% 0.75% UnchangedShares held: Q3 2025 27.0k, Q4 2025 27.0k, Q1 2026 27.0k, Q2 2026 27.0k
19 INSMED INC COM PAR $.01 INSM INSM 6,580 $701.6k0.53% 0.53% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 6.6k, Q2 2026 6.6k
20 ISHARES ETHEREUM TR SHS ETHA ETHA 50,549 $601.0k0.46% 0.46% UnchangedShares held: Q3 2025 50.5k, Q4 2025 50.5k, Q1 2026 50.5k, Q2 2026 50.5k
21 ISHARES BITCOIN TRUST ETF SHS BEN INT IBIT IBIT 15,968 $531.6k0.40% 0.40% UnchangedShares held: Q3 2025 16.0k, Q4 2025 16.0k, Q1 2026 16.0k, Q2 2026 16.0k
22 CHIME FINL INC COM SHS CL A CHYM CHYM 21,075 $431.6k0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 21.1k
23 RANI THERAPEUTICS HLDGS INC COM CL A RANI RANI 493,584 $375.3k0.29% 0.29% UnchangedShares held: Q3 2025 493.6k, Q4 2025 493.6k, Q1 2026 493.6k, Q2 2026 493.6k
24 ENTRADA THERAPEUTICS INC COM TRDA TRDA 49,082 $361.2k0.27% 0.27% UnchangedShares held: Q3 2025 49.1k, Q4 2025 49.1k, Q1 2026 49.1k, Q2 2026 49.1k
25 BOLT BIOTHERAPEUTICS INC COM NEW BOLT BOLT 5,000 $19.2k0.01% 0.01% ReducedShares held: Q3 2025 58.3k, Q4 2025 58.3k, Q1 2026 29.2k, Q2 2026 5.0k -24.2k -24,250 -82.9%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASCENDIS PHARMA A/S 13,600 $3.1m13.6k shares